Last updated on November 2017

A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis


Brief description of study

A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis

Detailed Study Description

The objective of this study is to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.

Clinical Study Identifier: TX3249

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Renee Smith

University of South Florida- Asthma, Allergy, and Immunology Clinical Research Unit
Tampa, FL USA
  Connect »